论文部分内容阅读
目的分析前列腺增生电切术后再次尿潴留的原因,有效降低术后发生尿潴留的几率,提高治疗效果。方法前列腺增生电切术患者400例,随机均分为两组。观察组于术后拔除导管前将膀胱内残留腺体及血块冲洗干净,并口服盐酸坦索罗辛;对照组于术后留置导管5 d后将导管拔除。观察两组患者再次尿潴留情况。结果对照组再次尿潴留发生率为20.00%,治疗组为9.00%,两组比较差异有统计学意义(P<0.05)。400例患者中58例发生再次尿潴留,发生率为14.50%,其中前列腺体残留28例,膀胱颈口水肿17例,神经源性膀胱13例。结论对于进行前列腺增生电切术患者,前列腺体残留、膀胱颈口水肿及神经源性膀胱是发生再次尿潴留的原因,针对性进行药物治疗,有助于降低再次出现尿潴留的发生率。
Objective To analyze the causes of urinary retention after prostatic hyperplasia resection and reduce the incidence of postoperative urinary retention and improve the therapeutic effect. Methods 400 cases of benign prostatic hyperplasia resection, were randomly divided into two groups. In the observation group, the residual glands and blood clots in the bladder were washed before the catheter was removed and tamsulosin hydrochloride was orally administered. The control group was catheterized after 5 days of catheter placement. Observe urinary retention in two groups again. Results The incidence of urinary retention was 20.00% in the control group and 9.00% in the treatment group. There was significant difference between the two groups (P <0.05). Of the 400 patients, 58 cases had re-urinary retention, the incidence rate was 14.50%, of which 28 cases of residual prostate, bladder neck edema in 17 cases, 13 cases of neurogenic bladder. Conclusions For the patients with benign prostatic hyperplasia, prostate residual, bladder neck edema and neurogenic bladder are the causes of re-urinary retention, targeted drug treatment, help to reduce the incidence of reoccurrence of urinary retention.